← Leaderboards
Joshua D.i. Ellenhorn
City Of Hope/Beckman Research Institute
$799,836
Attributed
$799,836
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $304.5K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$799,836 · 5
By mechanism
R21$593,736 · 1
R29$199,800 · 1
M01$6,300 · 3
Top collaborators
No co-investigators on record.
Most similar at City Of Hope/Beckman Research Institute
Same institution · by research overlap
- Stephen J Forma$14,356,218
- Laurence J.n. Cooper$14,619,391
- Chih-Pin Liu$3,240,652
- Defu Zeng$13,295,342
- James H Doroshow$6,200,078
Others in their field
Top investigators on “P53 Gene /Protein”
- Carol Prives · Icahn School Of Medicine At Mount Sinai$12,538,956
- Margaret R. Wrensch · University Of California San Francisco$6,944,039
- Andrei V Gudkov · University Of Illinois At Chicago$6,669,890
- Tyler E Jacks · Massachusetts Institute Of Technology$5,782,860
- Timothy J Yeatman · University Of South Florida$5,430,738
- Lawrence A. Donehower · Baylor College Of Medicine$4,852,912
Research focus
P53 Gene /ProteinNeoplasm /Cancer ImmunotherapyCancer PatientBloodClone CellsComputer Retrieval Of Information On Scientific Projects DatabaseDesignImmuneBreast NeoplasmsEvaluationFundingFutureGene MutationGrantHelper T LymphocyteCytotoxic T LymphocyteImmune ResponseImmunityInstitutionLaboratoriesLaboratory MouseLeukocyte Activation /TransformationLymph NodesCells
Grant awards (7)
EVALUATION OF THE USE OF POXVIRUS VACCINES TO STIMULATE P53 SPECIFIC IMMUNITY$1,201
M01 · FY2008 · RR · contact PI
EVALUATION OF THE USE OF POXVIRUS VACCINES TO STIMULATE P53 SPECIFIC IMMUNITY$968
M01 · FY2007 · RR · contact PI
CLINICAL EVALUATION OF A POXVIRUS VACCINE TARGETING P53$293,338
R21 · FY2006 · CA · contact PI
CLINICAL EVALUATION OF A POXVIRUS VACCINE TARGETING P53$300,398
R21 · FY2005 · CA
EVALUATION OF THE USE OF POXVIRUS VACCINES TO STIMULATE P53 SPECIFIC IMMUNITY$4,131
M01 · FY2005 · RR
P53 DIRECTED IMMUNOTHERAPY OF BREAST CANCER$99,160
R29 · FY2001 · CA
P53 DIRECTED IMMUNOTHERAPY OF BREAST CANCER$100,640
R29 · FY2000 · CA